Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Management of arrhythmia recurrence in patients with pulmonary vein stenosis following atrial fibrillation ablation

Thomas Fink*, Roland Richard Tilz, Christian Hendrik Heeger, Michael Schlüter, Sebastian Feickert, Laura Rottner, Bruno Reissmann, Christine Lemes, Hannes Alessandrini, Tilman Maurer, Shibu Mathew, Andreas Rillig, Andreas Metzner, Feifan Ouyang, Karl Heinz Kuck

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Aims: Arrhythmia recurrence is a common clinical problem in patients with pulmonary vein stenosis (PVS) following catheter ablation of atrial fibrillation. The study sought to analyse the management of arrhythmia recurrence in patients with PVS. Methods and results: Retrospective analysis was performed on 29 patients with high-degree PVS. Follow-up contained clinical visits, Holter-electrocardiogram recordings and invasive pulmonary vein (PV) angiography and electrophysiological studies. Arrhythmia recurrence was observed in 18 patients (62%) after PVS formation. Fifteen of 18 patients (83.3%) with and 1 of 11 patients (9.1%) without arrhythmia recurrence had electrical PV reconnection (P = 0.0003). In 14 of 16 patients repeat pulmonary vein isolation (PVI) was conducted (radiofrequency ablation in 12 and cryoballoon ablation in 2 cases). Repeat PVI was successful in all PVs in nine patients and incomplete in five patients (failed attempt in two patients with stent implantation, no attempt in three patients with stenotic PVs). Freedom from arrhythmia recurrence was estimated at 56.3% [95% confidence interval (CI) 36.4-72.0%] after 24 months. At the end of the follow-up, complete PVI was documented in 19 of 23 patients (82.6%) with stable sinus rhythm and in 2 of 6 patients with arrhythmia recurrence (33.3%) (P = 0.0335). The Kaplan-Meier estimate of recurrence-free survival of restenosis after interventional PVS treatment was similar in patients without and with repeat ablation [75.6% (95% CI 57.0-94.3%) and 67.0% (95% CI 43.2-90.7%) after 500 days, P = 0.77]. Conclusions: Pulmonary vein reconnection is the major driver of arrhythmia recurrence in PVS patients. Repeat PVI is feasible and does not lead to progression of PVS or restenosis if the procedure is carefully performed.

OriginalspracheEnglisch
ZeitschriftEuropace
Jahrgang21
Ausgabenummer10
Seiten (von - bis)1494-1501
Seitenumfang8
ISSN1099-5129
DOIs
PublikationsstatusVeröffentlicht - 01.10.2019

Fördermittel

Conflict of interest: K.-H.K. reports having received consulting fees/honoraria from Biosense Webster, Medtronic, Boston Scientific, and Abbott. A.M. reports having received speaker’s honoraria from Medtronic. R.R.T. reports having received research grants from St. Jude Medical; speaker’s honoraria from Biosense Webster, Biotronik, Pfizer, Topera, Bristol-Myers Squibb, Bayer, and Sanofi Aventis. The other authors report no relevant conflicts of interest.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Management of arrhythmia recurrence in patients with pulmonary vein stenosis following atrial fibrillation ablation“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren